Similarly, miR-103a-2, which is upregulated in NAFLD, induces insulin resistance by targeting caveolin-1 (Cav1), a critical regulator of the insulin receptor stability and insulin action [6]. This evidence concerns the gene CAV1 and metabolic dysfunction-associated steatotic liver disease.